Fennec Pharmaceuticals (FENC) Enterprise Value (2016 - 2025)
Fennec Pharmaceuticals' Enterprise Value history spans 15 years, with the latest figure at -$36.8 million for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 38.12% year-over-year to -$36.8 million, compared with a TTM value of -$36.8 million through Dec 2025, down 38.12%, and an annual FY2025 reading of -$36.8 million, down 38.12% over the prior year.
- Enterprise Value for Q4 2025 was -$36.8 million at Fennec Pharmaceuticals, down from -$21.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$12.4 million in Q3 2023, with the low at -$51.2 million in Q1 2024.
- Average Enterprise Value over 5 years is -$25.3 million, with a median of -$23.8 million recorded in 2022.
- Year-over-year, Enterprise Value soared 58.33% in 2023 and then crashed 285.74% in 2024.
- Tracing FENC's Enterprise Value over 5 years: stood at -$24.3 million in 2021, then rose by 2.31% to -$23.8 million in 2022, then soared by 44.19% to -$13.3 million in 2023, then crashed by 100.72% to -$26.6 million in 2024, then plummeted by 38.12% to -$36.8 million in 2025.
- Per Business Quant, the three most recent readings for FENC's Enterprise Value are -$36.8 million (Q4 2025), -$21.9 million (Q3 2025), and -$18.7 million (Q2 2025).